Using Val-boroPro, 1G244 and some isoindoline derivatives to inhibit DPP9 induces significant cell death in many human acute myeloid leukemia (AML) cell lines, suggesting a therapeutic potential of DPP9-selective inhibition in AML [109]. Here, DPP9 is linked to acute myeloid leukemia.